In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
All content for The Analytical Wavelength is the property of ACD/Labs and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
Are we Effectively Harnessing the Power of Data? Reflections from ACS Fall 2023
The Analytical Wavelength
19 minutes
2 years ago
Are we Effectively Harnessing the Power of Data? Reflections from ACS Fall 2023
We all know that data is powerful, but are you maximizing your data? Our very own Jesse Harris recently attended ACS Fall 2023, where the theme this year was “Harnessing the Power of Data”. Not only did he present, but he also conducted a survey to gather intel about the use of chemical software. Speaking with a variety of backgrounds, Jesse delved into details about analytical data processing software uses and challenges. This conversation with Jesse lets us dive a little deeper ...
The Analytical Wavelength
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
